The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gulecha Investment & Trading Co Pvt Ltd<BR>
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gulecha Investment & Trading Co. Pvt. Ltd., part of the promoter group of Bacil Pharma Ltd, has sold its entire holding of 10,800 equity shares (0.075% of total share capital) through a market sale on 24 December 2025. The disclosure was filed under SEBI Regulation 29(2) of the Takeover Regulations. After this sale, the entity holds zero shares in the company. Bacil Pharma's total equity capital remains unchanged at 14,353,000 shares of Rs. 10 each. The size of the transaction is very small and not material to the overall promoter holding or company control.
This is a token exit by a promoter-group entity with negligible impact on ownership structure, since the stake sold is only 0.075% of capital. Retail investors are unlikely to see any meaningful price or control impact from this disclosure.